Boston, MA, United States of America

Qi Tang

This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qi Tang. Retrieved from https://idiyas.com/inventor/qi-tang-y1be8nso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Qi Tang in SARS-CoV-2 Modulation

Introduction

Qi Tang is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of biotechnology, particularly in the fight against viral infections. His work focuses on developing novel solutions to combat SARS-CoV-2, the virus responsible for COVID-19.

Latest Patents

Qi Tang holds a patent for "Oligonucleotides for SARS-CoV-2 modulation." This patent discloses novel SARS-CoV-2 targeting sequences. The invention provides innovative oligonucleotides aimed at the treatment of SARS-CoV-2 infection, showcasing his commitment to addressing critical health challenges.

Career Highlights

Qi Tang is affiliated with the University of Massachusetts, where he continues to advance his research and innovation efforts. His work has garnered attention for its potential impact on public health and disease management.

Collaborations

Some of his notable coworkers include Anastasia Khvorova and Jonathan Watts. Their collaborative efforts contribute to the advancement of research in the field of virology and therapeutic development.

Conclusion

Qi Tang's innovative work in developing oligonucleotides for SARS-CoV-2 modulation highlights his dedication to improving health outcomes through scientific research. His contributions are vital in the ongoing battle against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…